Counterforce Health (Page 120)

More issues

Get Crysvita (burosumab) Covered by Cigna in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Crysvita Covered by Cigna in Illinois Eligibility: Crysvita (burosumab) requires prior authorization from Cigna for X-linked hypophosphatemia (XLH) or tumor-induced osteomalacia (TIO). Fastest path: Have your specialist submit the Cigna Crysvita CCRD Prior Authorization Form with genetic testing (XLH) or tumor documentation (TIO), baseline fasting serum phosphorus

If Strimvelis (ADA-SCID Gene Therapy) Isn't Approved by Blue Cross Blue Shield in Florida: Alternative Treatments & Exception Paths

Answer Box: Your Options When Strimvelis Gene Therapy Is Denied If Blue Cross Blue Shield (BCBS) in Florida denies Strimvelis gene therapy for ADA-SCID, you have three main paths: PEG-ADA enzyme replacement therapy as a bridge treatment, allogeneic stem cell transplant if a donor is available, or formulary exception appeal

Work With Your Doctor to Get Signifor/Signifor LAR (Pasireotide) Approved by Cigna in Ohio: Complete Provider Partnership Guide

Answer Box: Getting Cigna to Cover Signifor/Signifor LAR in Ohio Eligibility: Cigna covers Signifor/Signifor LAR (pasireotide) for adults with Cushing's disease when surgery isn't an option or wasn't curative, and for acromegaly after failing first-generation somatostatin analogs. Fastest path: Have your endocrinologist

How to Get Entresto (sacubitril/valsartan) Covered by Cigna in Florida: Appeals, Forms, and Medical Necessity Requirements

Quick Answer: Getting Entresto Covered by Cigna in Florida Fastest path to approval: Submit prior authorization with documented heart failure diagnosis (LVEF ≤40%), NYHA class, and prior ACE inhibitor/ARB failure or intolerance. If denied, file internal appeal within 180 days citing Florida step-therapy protections. Start today: Call Cigna at

Do You Qualify for Waylivra (Volanesorsen) Coverage by Blue Cross Blue Shield in New Jersey? Decision Tree & Next Steps

Answer Box: Quick Eligibility Check Getting Waylivra (volanesorsen) covered by Blue Cross Blue Shield in New Jersey requires meeting specific criteria. Since Waylivra is not FDA-approved in the US, coverage typically requires a non-formulary exception through Blue Cross Blue Shield's prior authorization process. You'll need: (1)

Do You Qualify for Besponsa Coverage by Cigna in Illinois? Decision Tree & Appeal Guide

Answer Box: Your Path to Besponsa Coverage in Illinois Yes, you likely qualify if you have CD22-positive relapsed/refractory B-cell precursor ALL after failing at least one prior therapy. Cigna requires prior authorization using their Besponsa CCRD form. First step today: Confirm CD22 positivity in your pathology report and gather

How to Get Fintepla (fenfluramine) Covered by Blue Cross Blue Shield in Georgia: Complete Prior Authorization Guide

Answer Box: Getting Fintepla Covered in Georgia To get Fintepla (fenfluramine) covered by Blue Cross Blue Shield in Georgia, you'll need prior authorization showing: (1) confirmed Dravet syndrome or Lennox-Gastaut syndrome diagnosis, (2) documented failure of 2-3 generic anti-seizure medications, and (3) enrollment in the REMS program with

How to Get Fintepla (Fenfluramine) Covered by Aetna (CVS Health) in New York: Complete Guide to Prior Authorization and Appeals

Answer Box: Fastest Path to Fintepla Coverage Is Fintepla covered by Aetna (CVS Health) in New York? Yes, but requires prior authorization for seizures associated with Dravet syndrome or Lennox-Gastaut syndrome in patients ≥2 years old. Fastest approval path: (1) Enroll in the FINTEPLA REMS program with baseline echocardiogram, (2)

How to Get Ofev (nintedanib) Covered by Blue Cross Blue Shield in Washington: Forms, Appeals & Success Strategies

Answer Box: Getting Ofev Covered by Blue Cross Blue Shield in Washington Ofev (nintedanib) requires prior authorization from all Blue Cross Blue Shield plans in Washington (Premera, Regence, and FEP Blue). Success requires: (1) pulmonologist diagnosis of IPF or progressive fibrosing ILD, (2) HRCT showing fibrosis pattern, and (3) baseline

Denied for Turalio (pexidartinib) by UnitedHealthcare in Florida? How to Appeal (Templates & Timelines)

Answer Box: Getting Turalio (pexidartinib) Covered by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Turalio (pexidartinib) with strict criteria: confirmed TGCT diagnosis, unresectable disease, and REMS enrollment. If denied, request a peer-to-peer review within 24-72 hours, then file internal appeals within 180 days. Florida offers binding external review through